Detalhe da pesquisa
1.
Advancing structured decision-making in drug regulation at the FDA and EMA.
Br J Clin Pharmacol
; 87(2): 395-405, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529733
2.
ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations.
Value Health
; 23(8): 1040-1048, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32828216
3.
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.
Br J Clin Pharmacol
; 89(9): 2646-2648, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455605
4.
Literature review of visual representation of the results of benefit-risk assessments of medicinal products.
Pharmacoepidemiol Drug Saf
; 25(3): 238-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26521865
5.
Recommendations for benefit-risk assessment methodologies and visual representations.
Pharmacoepidemiol Drug Saf
; 25(3): 251-62, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800458
6.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Pharmacoepidemiol Drug Saf
; 23(7): 667-78, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821575
7.
Estimating the harms of nicotine-containing products using the MCDA approach.
Eur Addict Res
; 20(5): 218-25, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714502
8.
Modelling the risk-benefit impact of H1N1 influenza vaccines.
Eur J Public Health
; 23(4): 674-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23402804
9.
E-cigarettes are less harmful than smoking.
Lancet
; 387(10024): 1160-2, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025332
10.
The value of real world evidence: The case of medical cannabis.
Front Psychiatry
; 13: 1027159, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405915
11.
A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.
Cannabis Cannabinoid Res
; 7(4): 482-500, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998895
12.
Drug harms in the UK: a multicriteria decision analysis.
Lancet
; 376(9752): 1558-65, 2010 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21036393
13.
So near yet so far: why won't the UK prescribe medical cannabis?
BMJ Open
; 10(9): e038687, 2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958492
14.
Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain.
J Pain Res
; 13: 1969-1977, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801852
15.
Medical cannabis in the UK: From principle to practice.
J Psychopharmacol
; 34(9): 931-937, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522058
16.
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex.
Eur Urol Focus
; 6(3): 522-530, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623981
17.
Nuclear risk management on stage: a decision analysis perspective on the UK's Committee on Radioactive Waste Management.
Risk Anal
; 29(5): 764-79, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19178656
18.
Quantifying Preferences in Drug Benefit-Risk Decisions.
Clin Pharmacol Ther
; 106(5): 955-959, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929257
19.
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulation.
Int J Drug Policy
; 56: 144-152, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459211
20.
Corrigendum re "Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex" [Eur Urol Focus 2020;6:522-30].
Eur Urol Focus
; 8(1): 360-361, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422458